Related references
Note: Only part of the references are listed.Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma
P. Hofman et al.
ANNALS OF ONCOLOGY (2012)
Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
V. Hofman et al.
CYTOPATHOLOGY (2012)
Worse Disease-Free Survival in Never-Smokers with ALK plus Lung Adenocarcinoma
Ping Yang et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR
Shang-Gin Wu et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
Matthew G. Krebs et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
ALK translocation is associated with ALK immunoreactivity and extensive signet-ring morphology in primary lung adenocarcinoma
Sanjay Popat et al.
LUNG CANCER (2012)
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas
Akihiko Yoshida et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
E. Bria et al.
ANNALS OF ONCOLOGY (2011)
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
A. Lecharpentier et al.
BRITISH JOURNAL OF CANCER (2011)
Seventh Edition of the Cancer Staging Manual and Stage Grouping of Lung Cancer Quick Reference Chart and Diagrams
Omar Lababede et al.
CHEST (2011)
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
Veronique Hofman et al.
CLINICAL CANCER RESEARCH (2011)
ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
Johannes M. Heuckmann et al.
CLINICAL CANCER RESEARCH (2011)
New Strategies for Treatment of ALK-Rearranged Non-Small Cell Lung Cancers
Takaaki Sasaki et al.
CLINICAL CANCER RESEARCH (2011)
Targeting Anaplastic Lymphoma Kinase in Lung Cancer
Alice T. Shaw et al.
CLINICAL CANCER RESEARCH (2011)
Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method
Veronique Hofman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non-Small-Cell Lung Cancer
Matthew G. Krebs et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma IHC Score Algorithm for FISH
Eunhee S. Yi et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
Alice T. Shaw et al.
LANCET ONCOLOGY (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
Therapeutic strategies to overcome crizotinib resistance in non-small cell lung cancers harboring the fusion oncogene EML4-ALK
Ryohei Katayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
David E. Gerber et al.
CANCER CELL (2010)
Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer
Atsuko Kitamura et al.
CLINICAL CANCER RESEARCH (2010)
The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer
Fred R. Hirsch et al.
CLINICAL CANCER RESEARCH (2010)
The biology and treatment of EML4-ALK non-small cell lung cancer
Takaaki Sasaki et al.
EUROPEAN JOURNAL OF CANCER (2010)
Circulating tumour cells: their utility in cancer management and predicting outcomes
Matthew G. Krebs et al.
Therapeutic Advances in Medical Oncology (2010)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2009)
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
Susan D. Richman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
Jussi P. Koivunen et al.
CLINICAL CANCER RESEARCH (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Patrizia Paterlini-Brechot et al.
CANCER LETTERS (2007)
Prognostic assessment after surgical resection for non-small cell lung cancer:: Experiences in 2083 patients
Joachim Pfannschmidt et al.
LUNG CANCER (2007)
Prognosis of 6644 resected non-small cell lung cancers in Japan: A Japanese lung cancer registry study
T Goya et al.
LUNG CANCER (2005)
Sensitive Sequencing method for KRAS mutation detection by pyrosequencing
S Ogino et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: The Japanese experience
T Naruke et al.
ANNALS OF THORACIC SURGERY (2001)
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA
MTM van Rens et al.
CHEST (2000)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
